Genetically increased antioxidative protection and decreased chronic obstructive pulmonary disease.
about
Pathogenic triad in COPD: oxidative stress, protease-antiprotease imbalance, and inflammationSuperoxide dismutase 3, extracellular (SOD3) variants and lung functionFunctional variants of antioxidant genes in smokers with COPD and in those with normal lung functionUpdates on the COPD gene listOxidative Stress and Therapeutic Development in Lung DiseasesOxidative stress and glutathione in TGF-beta-mediated fibrogenesisGlucocorticoid insensitivity as a future target of therapy for chronic obstructive pulmonary diseaseMendelian randomization in cardiometabolic disease: challenges in evaluating causality.Candidate genes controlling pulmonary function in mice: transcript profiling and predicted protein structure.Framingham Heart Study genome-wide association: results for pulmonary function measures.The COPD genetic association compendium: a comprehensive online database of COPD genetic associationsSIRT1 protects against cigarette smoke-induced lung oxidative stress via a FOXO3-dependent mechanismRedox control of asthma: molecular mechanisms and therapeutic opportunities.Genetic variation in antioxidant enzymes, cigarette smoking, and longitudinal change in lung functionExtracellular superoxide dismutase and risk of COPD.MMP12, lung function, and COPD in high-risk populationsPolymorphisms in the superoxide dismutase-3 gene are associated with emphysema in COPD.Extracellular superoxide dismutase protects against pulmonary emphysema by attenuating oxidative fragmentation of ECM.A new mouse model for temporal- and tissue-specific control of extracellular superoxide dismutase.Genetic variation and gene expression in antioxidant related enzymes and risk of COPD: a systematic review.A common polymorphism in extracellular superoxide dismutase affects cardiopulmonary disease risk by altering protein distribution.The genetics of chronic obstructive pulmonary disease.The cellular distribution of extracellular superoxide dismutase in macrophages is altered by cellular activation but unaffected by the naturally occurring R213G substitutionCOPD in Nonsmokers: Reports from the Tunisian Population-Based Burden of Obstructive Lung Disease StudySuperoxide dismutase 3 controls adaptive immune responses and contributes to the inhibition of ovalbumin-induced allergic airway inflammation in mice.Variability in small airway epithelial gene expression among normal smokers.Update in chronic obstructive pulmonary disease 2006.Superoxide dismutase 3 polymorphism associated with reduced lung function in two large populations.Extracellular superoxide dismutase haplotypes are associated with acute lung injury and mortality.National Emphysema Treatment Trial state of the art: genetics of emphysemaMarkers of early disease and prognosis in COPD.Endogenous enzymes (NOX and ECSOD) regulate smoke-induced oxidative stress.Level and course of FEV1 in relation to polymorphisms in NFE2L2 and KEAP1 in the general populationExtracellular Superoxide Dismutase Enhances Recruitment of Immature Neutrophils to the Liver.Meta-analyses on suspected chronic obstructive pulmonary disease genes: a summary of 20 years' research.Current perspectives of oxidative stress and its measurement in chronic obstructive pulmonary disease.Current concepts on oxidative/carbonyl stress, inflammation and epigenetics in pathogenesis of chronic obstructive pulmonary disease.Oxidative stress in asthmaSustained lung activity of a novel chimeric protein, SOD2/3, after intratracheal administration.Zinc(II) ion promotes anti-inflammatory effects of rhSOD3 by increasing cellular association.
P2860
Q24615052-E2F14844-F2CD-43CB-9666-5E3BB6595E18Q24657554-C11EDDC3-C127-4E8E-85ED-A1995C5A7E6FQ24681700-91C8A2CC-798B-4D69-B455-024825160F41Q26824935-F2EB32CA-DE09-4ADD-ACDB-DF553B2AC282Q28390572-60F3C3F9-D2AB-4752-9B52-F19C128897F9Q28393454-171D9DBB-896C-4BDF-A866-ACF1EBC2DB7EQ28761895-1F99E9F4-45A6-4FFF-B98D-3F323BECBCFBQ30234302-8FBDBAE8-1EAF-4D3A-A011-9338583DD6D3Q30364215-06F36EEA-1F8B-43B0-9A0E-E31485ECFF9CQ33300819-3D5335D0-D6B0-452B-BC6B-AD27716F9F79Q33559787-CA2B2B81-98DD-41CB-A21E-6F171930204CQ33568637-1A4DD512-B1B6-4372-8FF2-E39121F29DF1Q33668491-10894DB1-173E-4C3B-B56F-3D0BEC9FE2E6Q33765854-60F728B4-137E-416F-B910-6A7072517843Q33821221-96D202BF-B0B6-4AAA-9C47-5C6E5EF561EDQ33994495-3EE08187-0895-4B8E-BB86-E6C1CFFEF30FQ34074050-F31AC03A-7AA3-4749-84A9-419755D8F582Q34100348-64FCD942-962E-4111-9709-1B6C6E64C848Q34477148-3BFA1B9A-302F-4742-B12B-6CA92178CCDAQ34547662-22DB1A95-A6D1-4DED-88D3-184656E45EDCQ34735375-5A25BF96-B415-48B3-B250-61FB6EF3C61CQ35113365-56EFDC5D-AE0A-4986-BE8D-9B18B392EFE8Q35633025-E1E22A85-D8B8-4680-821B-67541CC83EAFQ35968539-DFCABA07-0574-4CC1-8070-66F190A68F06Q36218764-7E6147B5-6922-4470-9509-A21F2C0F663FQ36784448-185E08D3-5E44-4316-B4FB-AB84591BFD06Q36838782-D2C832B0-6CB4-4D39-A073-7316DB1FF1AAQ36960786-1FF959FC-8E87-4FBE-AD2B-362D981F1A2BQ37077798-44A690B2-EE88-4B44-8D47-71DB068303F0Q37103683-5C8E440A-C71E-4173-B144-686169FFCA33Q37168317-44DAEE98-0A1E-4871-ADED-08DA5C0BBD96Q37192215-3A5796DD-839B-4E1B-8134-1611DF6C60ACQ37334890-74B1AA92-978A-4F2D-B06B-A73A017EE3F3Q37424953-84E24E42-F2F4-461F-985F-90129B6EF9C6Q37553688-3CE05D1D-834A-4732-BB4C-A06BA32971AEQ37776727-FA42FD98-A1F6-4E74-9631-5357EB621616Q37836078-4FC865A4-125C-46E5-9C87-A6F5B982A5FFQ38069882-39F520B9-B58A-4616-A5EF-B0C1F831CBC6Q41298807-769E6EAD-C85F-4711-8BF8-C29C32E12ABCQ42120465-89DEDFA2-DDFB-4D8A-9535-E9BA76B6E395
P2860
Genetically increased antioxidative protection and decreased chronic obstructive pulmonary disease.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Genetically increased antioxid ...... obstructive pulmonary disease.
@en
Genetically increased antioxid ...... obstructive pulmonary disease.
@nl
type
label
Genetically increased antioxid ...... obstructive pulmonary disease.
@en
Genetically increased antioxid ...... obstructive pulmonary disease.
@nl
prefLabel
Genetically increased antioxid ...... obstructive pulmonary disease.
@en
Genetically increased antioxid ...... obstructive pulmonary disease.
@nl
P2093
P2860
P1476
Genetically increased antioxid ...... obstructive pulmonary disease.
@en
P2093
Klaus Juul
Peter Lange
Stefan Marklund
P2860
P304
P356
10.1164/RCCM.200509-1387OC
P407
P577
2006-01-06T00:00:00Z